BENEDICTE PONTIER

Dr. BENEDICTE PONTIER


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ASAnna SONTHEIMER
Anna SONTHEIMER
BPBENEDICTE PONTIER
BENEDICTE PONTIER
BCBéatrice Claise
Béatrice Claise
CCCarine Chassain
Carine Chassain
JCJérôme Coste
Jérôme Coste
JLJean-Jacques Lemaire
Jean-Jacques Lemaire
Chronic disorders of consciousness (DOC) encompass unresponsive wakefulness syndrome and minimally conscious state. Their anatomo-functional correlates are not clearly defined yet, although impairments of functional cortical networks have been reported, as well as the implication of the thalamus and deep brain structures. However, the pallidal functional connectivity with the thalamus and the cortical networks has not been studied so far. Using resting-state functional MRI, we conducted a functional connectivity study between the pallidum, the thalamus and the cortical networks in 13 patients with chronic DOC and 19 healthy subjects. We observed in chronic DOC patients that the thalami were no longer connected to the cortical networks, nor to the pallidums. Concerning the functional connectivity of pallidums, we reported an abolition of the negative correlation with the default mode network, and of the positive correlation with the salience network. The disrupted functional connectivity observed in chronic DOC patients between subcortical structures and cortical networks could be related to the mesocircuit model. A better understanding of the DOC underlying physiopathology could provide food for thought for future therapeutic proposals.

26 June 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
KBKarelle Bénistan
Karelle Bénistan
BPBENEDICTE PONTIER
BENEDICTE PONTIER
CLCatherine Leblond
Catherine Leblond
OFOphélie Flageul
Ophélie Flageul
GGGwenvael Le Guicher
Gwenvael Le Guicher
FGFabrice Gillas
Fabrice Gillas
Patients with Ehlers-Danlos Syndrome (EDS) frequently suffer from severe chronic pain. We carried out an observational cohort study to assess the effectiveness of compression garments (CGs) for reducing this pain. Patients with non-vascular EDS were given custom-made Cerecare® CGs during a visit to a specialist clinic (visit V0). They were followed up over 2 years with visits every 6 months (V1–V4). At each visit, pain was assessed for the joints treated with CGs using a visual analogue scale (VAS; 0–100 mm). Additional measures were obtained to assess neuropathic pain (painDETECT questionnaire), proprioception/balance (Berg Balance Scale), and functional independence, amongst others. Data were analyzed for 67 patients with EDS (hypermobile: 91%; classical: 6%; kyphoscoliotic: 3%). For the most painful joint, the mean VAS rating was 71.5 ± 22.8 mm at V0; this decreased to 53.5 ± 25.5 mm at V1 and 45.7 ± 29 mm at V4 (t-tests: p < 0.0001). From V0 to V4, improvements were also seen for pain at the other joints, neuropathic pain, functional independence, proprioception/balance, and the incidence of sprains and dislocations/subluxations, although not all comparisons were statistically significant (p < 0.05 level). These results indicate that CGs may effectively reduce the pain and joint instability in non-vascular EDS patients.

10 February 2024 in Genes
Verified
Journal Article
Open access
PDF file
ZOZangbéwendé Guy OUEDRAOGO
Zangbéwendé Guy OUEDRAOGO
CJCaroline Janel
Caroline Janel
AJAlexandre Janin
Alexandre Janin
GMGilles Millat
Gilles Millat
SLSarah Langlais
Sarah Langlais
ICIsabelle Creveaux
Isabelle Creveaux
Skeletal dysplasia, also called osteochondrodysplasia, is a category of disorders affecting bone development and children’s growth. Up to 552 genes, including fibroblast growth factor receptor 3 (FGFR3), have been implicated by pathogenic variations in its genesis. Frequently identified causal mutations in osteochondrodysplasia arise in the coding sequences of the FGFR3 gene: c.1138G>A and c.1138G>C in achondroplasia and c.1620C>A and c.1620C>G in hypochondroplasia. However, in some cases, the diagnostic investigations undertaken thus far have failed to identify the causal anomaly, which strengthens the relevance of the diagnostic strategies being further refined. We observed a Caucasian adult with clinical and radiographic features of achondroplasia, with no common pathogenic variant. Exome sequencing detected an FGFR3(NM_000142.4):c.1075+95C>G heterozygous intronic variation. In vitro studies showed that this variant results in the aberrant exonization of a 90-nucleotide 5′ segment of intron 8, resulting in the substitution of the alanine (Ala359) for a glycine (Gly) and the in-frame insertion of 30 amino acids. This change may alter FGFR3’s function. Our report provides the first clinical description of an adult carrying this variant, which completes the phenotype description previously provided in children and confirms the recurrence, the autosomal-dominant pathogenicity, and the diagnostic relevance of this FGFR3 intronic variant. We support its inclusion in routinely used diagnostic tests for osteochondrodysplasia. This may increase the detection rate of causal variants and therefore could have a positive impact on patient management. Finally, FGFR3 alteration via non-coding sequence exonization should be considered a recurrent disease mechanism to be taken into account for new drug design and clinical trial strategies.

1 July 2021 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
BPBENEDICTE PONTIER
BENEDICTE PONTIER
ASAnna Sontheimer
Anna Sontheimer
JCJérôme Coste
Jérôme Coste
YOYoussef El Ouadih
Youssef El Ouadih
ABAnne-Marie Briancon
Anne-Marie Briancon
JLJean-Jacques Lemaire
Jean-Jacques Lemaire